Lactobacillus casei
Lactobacillus casei (species-level entry, undesignated strain) is a broadly studied lactic acid bacterium encountered across fermented dairy and non-dairy foods. The indexed research for this species-level entry spans diverse topics, including immune stimulation in animal models, fermentation biochemistry, and food technology applications, without converging on a single well-characterized probiotic strain. Species-level data cannot be reliably attributed to any particular commercial or clinical preparation of L. casei without strain designation, and the indexed studies here do not constitute strain-specific clinical evidence.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 3,881 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 1,368 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+17 more symptoms
Strains of this species
3 strains of Lactobacillus casei in the index, with 731 linked papers between them.
Lactobacillus casei ATCC 334
Lactobacillus casei ATCC 334 is a well-characterized reference strain widely used in laboratory research to study probiotic biology, fermentation, and food technology.
Lactobacillus casei Shirota
Lactobacillus casei Shirota is one of the most extensively studied probiotic strains, with a research history spanning several decades.
Lactobacillus casei FG12
Lactobacillus casei FG12 is a novel probiotic strain with a single indexed publication, a 2025 rat study examining antioxidant activity and potential effects in a chemically induced cancer model.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
13899 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41910295 →A randomized controlled trial of probiotics to reduce the severity of oral mucositis in patients with oropharyngeal carcinoma undergoing concurrent chemoradiotherapy· Journal of Cancer Research and Therapeutics · 2026
-
[2]
Source →Lactobacillus casei Shirota intervention modulates the esophageal microbiome composition in Barrett’s esophagus· medRxiv · 2025
-
[3]
Source →The Effects of Probiotic Supplementation on Treatment Outcomes of Patients with Active Tuberculosis: A Systematic Review of Randomized Controlled Trials· Journal Of The Indonesian Medical Association · 2025
-
[4]
PMID 39952876 →Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients With Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis· Clinical Genitourinary Cancer · 2025
-
[5]
PMID 40877060 →Enhanced sleep quality and reduced indoxyl sulfate levels following probiotic supplementation were linked to gut microbiota modulation in hemodialysis patients· Journal of the Formosan Medical Association · 2025
-
[6]
PMID 41221154 →Lactobacillus casei ’s Antitumor Potential in Colorectal Cancer: Exploring Mechanisms—A Systematic Review· BioMed Research International · 2025
-
[7]
PMID 39858898 →Probiotics in the Management of Chronic Bacterial Prostatitis Patients: A Randomized, Double-Blind Trial to Evaluate a Possible Link Between Gut Microbiota Restoring and Symptom Relief· Microorganisms · 2025
-
[8]
PMID 39064686 →The Effect of Probiotics on the Management of Pain and Inflammation in Osteoarthritis: A Systematic Review and Meta-Analysis of Clinical Studies· Nutrients · 2024
-
[9]
PMID 38788020 →Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial· Medicine · 2024
-
[10]
PMID 38519563 →Lactobacillus casei Shirota probiotic drinks reduce antibiotic associated diarrhoea in patients with spinal cord injuries who regularly consume proton pump inhibitors: a subgroup analysis of the ECLISP multicentre RCT· Spinal Cord · 2024